In this Clinical Coffee Break, Dr. Petrini focuses on specific elements of caring for patients with personality disorders. This activity will provide a practical approach to establishing a contract with the patient as well as an overview of available drug options for patients with personality disorders.
Recognize the complexities of managing patients with chronic disease and accompanying depression and/or anxiety.
In this Clinical Coffee Break, Dr. Sanjay Mathew at Baylor College of Medicine answers frequently asked questions on the classification and management of major depressive disorder, with a particular focus on antidepressant medications and how to choose among and get the greatest benefit from these agents.
Two experts representing psychiatry and adolescent medicine from the Baylor College of Medicine provide insights into presentations of eating disorders in different patient populations in a lively interactive discussion.
In this activity, Dr. Wyatt will take a deeper dive in the subject of sleep disorders. He will explain in detail the concept of 'sleep switch' and the circadian modulation of the sleep-wake cycle. He will list the causes of daytime sleepiness and the methods to measure it and finally, discuss measures to counteract this increasingly common problem.
This Expert Perspective highlights the salient points of a recent article by Dr Eisen and colleagues published in the Journal of Clinical Psychiatry titled: Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse.
This lecture will provide an overview of recent developments in the treatment of major depressive disorder. The lecture will summarize current antidepressant medication options, and discuss augmentation strategies for patients with difficult-to-treat depression. Safety and efficacy information will be reviewed for several of the new FDA-approved medications for major depressive disorder.
We tend to think of advances in medicine as a new drug, laser, or surgical procedure, something high-tech and expensive. This presentation will discuss the power of comprehensive lifestyle changes, reviewing more than 30 years of research using high-tech, state-of-the-art measures to prove the power of low-tech, low-cost, and often ancient interventions. Also, the lecture will describe proven strategies for motivating people to make and maintain comprehensive lifestyle changes as well as how to personalize a way of eating and living based on an individual’s needs, genes, and preferences. Finally, the presentation will describe many of the health policy implications of comprehensive lifestyle changes as both medically effective and cost effective.
It is commonly difficult to obtain timely mental health referrals in many communities across the country, but many patients seen by primary care practitioners suffer from depression. Hence, primary care clinicians are commonly the first point of contact and treatment for patients with depression. This activity will review procedures to screen for depression, the relative efficacy of different antidepressants, and when to switch or augment antidepressant therapy. In addition, Dr. Smetana will discuss one of the most important factors in drug selection, i.e. how to exploit side effect profiles to advantage of patients.
Depression is a common but complex condition, requiring accurate diagnosis, and targeted stepwise pharmacologic and nonpharmacologic interventions. In this session, learn the DSM-5 diagnostic criteria for major depression, and how changes in DSM-5 affect the diagnosis and characterization of depressive disorders; how to apply simple, quick tools to screen for depression; and how to compare and contrast treatment modalities, including pharmacotherapy and cognitive behavioral therapy (CBT).
In the primary care setting, current needs for better identification, diagnosis and treatment of MDD require consistent use of best practices. These include: screening via standardized instruments, judicious treatment selection, appropriate treatment duration before switching agents, monitoring and intervention for residual symptoms and adverse events that may affect treatment persistence, support for patient adherence through relationship building and communication, effective interface with specialists and counselors, and methods to foster effective self-management. By following these practices, clinicians can improve their performance and improve outcomes for their patients with MDD.